skip to Main Content
bitcoin
Bitcoin (BTC) $ 98,423.37 4.86%
ethereum
Ethereum (ETH) $ 3,352.10 9.61%
tether
Tether (USDT) $ 1.00 0.19%
solana
Solana (SOL) $ 255.26 9.50%
bnb
BNB (BNB) $ 620.92 2.74%
xrp
XRP (XRP) $ 1.19 9.90%
dogecoin
Dogecoin (DOGE) $ 0.384997 3.56%
usd-coin
USDC (USDC) $ 0.999589 0.14%
staked-ether
Lido Staked Ether (STETH) $ 3,350.29 9.74%
cardano
Cardano (ADA) $ 0.804567 0.57%

Markets Spike as Coronavirus Vaccine Trial Shows 90% Success Rate

(Numstocker/Shutterstock)

Both bitcoin and the U.S. stock futures shot up on Monday after a U.S. pharmaceutical giant announced positive results from a large-scale clinical trial of a coronavirus vaccine.

  • Risk appetite improved as Pfizer said its experimental vaccine is 90% effective in preventing infections in the ongoing trials, Bloomberg reported.
  • The news raises hopes that there may soon be an effective treatment for COVID-19, which is again running rampant through regions such as the U.S. and Europe.
  • CoinDesk data shows that as the news broke, bitcoin jumped from $11,500 to $11,840 in the 15 minutes to 12:00 UTC.
  • That came as the futures tied to the S&P 500 surged over 100 points to reach a record high of $3,648, and Dow Jones futures rose 1500 points.
  • Gold, meanwhile, fell from $1,950 to $1,900 as investors sold safe-haven assets amid the rally on Wall Street.
  • The coronavirus pandemic brought the global economy to a near standstill in the second quarter and its recent resurgence is threatening to derail the fragile economic recovery.
  • The vaccine news, therefore, bodes well for growth-sensitive stocks and other risky assets.
  • While the S&P 500 futures continue to trade near record highs, bitcoin has erased gains to trade near $10,500.
  • The cryptocurrency’s rally from October lows below $10,500 has stalled below $16,000 over the past couple of days, but, on Sunday, a weekly close above last year’s high opened the door for a continued rally, possibly to a record high.
Loading data ...
Comparison
View chart compare
View table compare
Back To Top